Cutler Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $242K | Sell |
108,300
-102,200
| -49% | -$9.48M | 0.08% | 247 |
|
|
2023
Q4 | $437K | Buy |
210,500
+85,500
| +68% | +$6.35M | 0.04% | 468 |
|
|
2023
Q3 | $356K | Buy |
125,000
+40,700
| +48% | +$3.25M | 0.04% | 530 |
|
|
2023
Q2 | $310K | Sell |
84,300
-4,500
| -5% | -$376K | 0.04% | 470 |
|
|
2023
Q1 | $325K | Sell |
88,800
-57,300
| -39% | -$4.75M | 0.03% | 481 |
|
|
2022
Q4 | $252K | Sell |
146,100
-208,900
| -59% | -$16.9M | 0.02% | 677 |
|
|
2022
Q3 | $2.76M | Sell |
355,000
-46,600
| -12% | -$3.93M | 0.19% | 102 |
|
|
2022
Q2 | $2.8M | Sell |
401,600
-113,200
| -22% | -$8.5M | 0.2% | 110 |
|
|
2022
Q1 | $3.37M | Sell |
514,800
-417,100
| -45% | -$38.5M | 0.18% | 116 |
|
|
2021
Q4 | $3.21M | Buy |
931,900
+52,400
| +6% | +$6.32M | 0.13% | 161 |
|
|
2021
Q3 | $1.82M | Buy |
879,500
+562,300
| +177% | +$72.4M | 0.08% | 263 |
|
|
2021
Q2 | $611K | Sell |
317,200
-292,700
| -48% | -$38.5M | 0.03% | 666 |
|
|
2021
Q1 | $3.77M | Sell |
609,900
-78,400
| -11% | -$11.7M | 0.19% | 110 |
|
|
2020
Q4 | $1.34M | Sell |
688,300
-167,700
| -20% | -$21.5M | 0.06% | 309 |
|
|
2020
Q3 | $1.03M | Sell |
856,000
-39,400
| -4% | -$4.42M | 0.06% | 312 |
|
|
2020
Q2 | $1.35M | Buy |
895,400
+425,900
| +91% | +$41.9M | 0.09% | 232 |
|
|
2020
Q1 | $4.59M | Sell |
469,500
-198,000
| -30% | -$17.5M | 0.24% | 77 |
|
|
2019
Q4 | $1.05M | Buy |
667,500
+91,600
| +16% | +$7.92M | 0.06% | 253 |
|
|
2019
Q3 | $1.57M | Buy |
575,900
+440,300
| +325% | +$36.6M | 0.14% | 109 |
|
|
2019
Q2 | $119K | Sell |
135,600
-61,600
| -31% | -$5.25M | 0.01% | 997 |
|
|
2019
Q1 | $87K | Sell |
197,200
-280,900
| -59% | -$23.9M | 0.01% | 1083 |
|
|
2018
Q4 | $1.12M | Buy |
478,100
+280,100
| +141% | +$22.6M | 0.11% | 162 |
|
|
2018
Q3 | $87K | Sell |
198,000
-234,100
| -54% | -$22.7M | 0.01% | 1283 |
|
|
2018
Q2 | $530K | Sell |
432,100
-327,200
| -43% | -$30.1M | 0.04% | 418 |
|
|
2018
Q1 | $2.66M | Buy |
759,300
+242,200
| +47% | +$22.1M | 0.23% | 76 |
|
|
2017
Q4 | $666K | Sell |
517,100
-236,700
| -31% | -$19.8M | 0.03% | 436 |
|
|
2017
Q3 | $797K | Buy |
753,800
+20,800
| +3% | +$1.67M | 0.03% | 432 |
|
|
2017
Q2 | $676K | Buy |
733,000
+195,300
| +36% | +$13.9M | 0.03% | 547 |
|
|
2017
Q1 | $772K | Buy |
537,700
+81,600
| +18% | +$5.48M | 0.03% | 478 |
|
|
2016
Q4 | $1.37M | Buy |
456,100
+24,500
| +6% | +$1.51M | 0.05% | 304 |
|
|
2016
Q3 | $1.2M | Sell |
431,600
-228,700
| -35% | -$14.1M | 0.05% | 264 |
|
|
2016
Q2 | $2.55M | Buy |
660,300
+327,400
| +98% | +$17.9M | 0.13% | 116 |
|
|
2016
Q1 | $2.27M | Sell |
332,900
-333,500
| -50% | -$17.3M | 0.15% | 96 |
|
|
2015
Q4 | $2.35M | Buy |
+666,400
| New | +$45.5M | 0.13% | 135 |
|
Other funds holding XBI
ACA
Cutler Group's XBI Position: Q1 2024 in Review
Cutler Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2024, closing a stake of 62,433 shares — an estimated $5.79M sold.
Cutler Group first reported a position in XBI in Q4 2015 and held it in 28 quarters. The position peaked at $10.7M in Q1 2022. 780 funds tracked by Wall St. Rank hold XBI as of Q1 2024.
- Cutler Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2024 after selling out during the quarter.
- Cutler Group sold 62,433 State Street SPDR S&P Biotech ETF shares in Q1 2024, an estimated $5.79M.
- Cutler Group first reported a position in State Street SPDR S&P Biotech ETF in Q4 2015 and held it in 28 quarters.
- Cutler Group's State Street SPDR S&P Biotech ETF position peaked at $10.7M in Q1 2022.
- 780 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2024.
Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.